Docplix Co-Founders Dr. Ajay. Shukla, CIO and Dr. Varun Garg, CEO (from L-R)
  • Docplix is set to revolutionize healthcare in India by digitizing health records with an ABDM-compliant Electronic Health Record (EHR) system. This system features an integrated Decision Support System (DSS) and innovative visualization tools designed to enhance patient care and streamline clinic operations.
  • The funds raised will be allocated towards product development, AI integration, and market expansion.
  • Inflection Point Ventures has invested over ₹750 Crore in more than 200 startups to date.

Lucknow, 6th June 2024: Health-tech company Docplix has secured INR 1.2 Crore in a Bridge Round led by Inflection Point Ventures. The funds will be directed towards product development, AI integration, and market expansion. This initiative will enhance their EHR system, incorporate advanced AI capabilities for improved decision support and patient care, and extend their reach to larger clinics and hospitals.

DocPlix is dedicated to transforming healthcare in India by digitizing health records for 1.4 billion people. Their ABDM-compliant Electronic Health Record (EHR) system ensures secure and interoperable patient data management. DocPlix’s integrated Decision Support System (DSS) aids healthcare professionals in making informed decisions through data analytics. Additionally, innovative visualization tools simplify patient data understanding, enhancing patient care and clinic efficiency. DocPlix aims to create a more efficient, transparent, and patient-centric healthcare system in India.

Founded by Dr. Varun Garg (Co-Founder & CEO), a dentist with over 10 years of experience; Aayush Garg (Co-Founder & CTO), a B.Tech in CSE with over 8 years of experience in tech startups; and Dr. Ajay Shukla (Co-Founder & CIO), an endocrinologist with a DM from SGPGI, Lucknow, and over 8 years of experience in the field, DocPlix has a strong leadership team.

Vinay Bansal, Founder & CEO of Inflection Point Ventures, said, “The government’s Ayushman Bharat Digital Mission aims to create a health ID repository for all citizens, facilitating easy information exchange between doctors and patients. DocPlix is on a mission to integrate citizens and healthcare providers into a tech-enabled healthcare system, significantly improving patient diagnosis and treatment. At IPV, we invest in companies using technology for good, bringing real-life changes to users. DocPlix’s powerful platform, wellness programs, and efforts to address healthcare access in tier 2 and 3 towns drove our decision to invest.”

DocPlix has developed a comprehensive AI-enabled EHR system, establishing itself as a leader in digital healthcare solutions. With a significant presence across India, DocPlix serves over 2,000 doctors, extending its reach through programs and remote clinics in tier-2 and tier-3 cities to address healthcare needs in underserved areas. The company is experiencing rapid growth, boasting an impressive renewal rate of 93%. DocPlix plans to expand globally, starting with the USA in late 2024, aiming to enter lucrative and technologically advanced markets.

Dr. Varun Garg, Co-Founder & CEO of Docplix, said, “Our goal is to become the leading EHR provider in India, leveraging advanced technologies like AI and data analytics to transform healthcare delivery. With a strong foundation and the support of IPV, we are poised to scale globally, starting with the USA, while continuously innovating to meet the evolving needs of healthcare professionals and patients.”

DocPlix has achieved significant milestones, including the launch of its proprietary AI model, Pāṇini. The company has built an ecosystem with over 3,000 doctors and has emerged as a market leader in Uttar Pradesh and Uttarakhand.

In 2022, the Indian Electronic Health Record (EHR) market was valued at approximately $414 million, projected to reach $900 million by 2030. Globally, the EHR market was valued at $25 billion in 2022, expected to grow to $40 billion by 2032. Meanwhile, the Indian Lifestyle & Wellness market stood at $1,300 billion in 2024, while the global market reached $5,546 billion in 2023 and is forecasted to reach $9,245.8 billion by 2033.